摘要
目的探讨HCV RNA PCR水平对丙型肝炎病毒(HCV)/人类免疫缺陷病毒(HIV)合并感染自然进程的影响。方法采用实时荧光定量PCR方法检测HCV RNA,比较初次就诊高效反转录病毒治疗(HAART)前的HCV/HIV合并感染(HCV/HIV组)、HCV单纯感染(HCV组)、HIV单纯感染(HIV组)患者的HCV RNA、HIV RNA、CD4+T淋巴细胞计数、天冬氨酸转氨酶(AST)、总胆红素(TBIL)、透明质酸酶(HA)、层粘连蛋白(LN)、甘胆酸(CG)、Ⅲ型胶原(PCⅢ)、Ⅳ型胶原(CⅣ)、年龄等指标。结果 HCV/HIV组与HCV组和HIV组CD4+T淋巴细胞计数分别为139.75±91.586、647.16±363.379、288.0±219.6个/微升(P<0.01)。与HCV组患者的发病年龄分别为37±15和52±13岁(P<0.01)。HCV RNA分别为6.0417±0.93524和5.2553±1.62773log/ml(P<0.05);CⅣ分别为105.30±24.630和95.41±52.889ng/ml(P<0.05);CG分别为1444.98±1721.597、139.00±165.640μg/ml(P<0.01);PCⅢ分别为285.52±244.558、159.82±86.928ng/ml(P<0.01);ALT分别为104.42±107.90、46.22±32.589U/L(P<0.01)。与HIV组HIV RNA分别为4.8±0.9和4.1±1.0log/ml(P<0.01)。结论 HCV/HIV合并感染可以加重和加快HCV、HIV疾病的自然进程。高水平的HCV RNA是HCV/HIV合并感染患者的HCV、HIV疾病自然进程的危险因素之一。
Objective To investigate the impact of the HCV RNA levels of HCV/HIV co-infected patients on natural process of HCV and HIV disease.Methods We compared the levels of HCV RNA,HIV RNA,CD4 + T lymphocyte count and alanine aminotransferase (ALT),total bilirubin (TBIL),hyaluronidase (HA),laminin (LN),cholyglycine (CG),Ⅲ collagen (PC Ⅲ),Ⅳ collagen (C Ⅳ) and age of HIV/HCV co-infected patients group with HCV infected group and HIV infected group.Results The CD4 + T lymphocyte counts were 139.75 ± 91.586,647.16 ± 363.379,288.0 ± 219.6/μl in HCV/HIV group and HCV group and HIV group respectively (P <0.01),compared with HCV group and HIV group (P < 0.01).Compared with HCV group,the levels of HCV RNA was 6.0417 ± 0.93524 and 5.2553 ± 1.62773log/ml(P < 0.05),the levels of CIV,CG,PC Ⅲ,ALT were 105.30 ± 24.630 and 95.41 ± 52.889ng/ml(P <0.05) ;1444.98 ± 1721.597,139.00 ± 165.640μ g/ml(P <0.01) ;PC Ⅲ285.52 ± 244.558、159.82 ± 86.928ng/ml(P < 0.01) ;104.42 ± 107.9、46.22 ± 32.589U/L P < 0.01) and the age were (37 ± 15) and (52 ± 13) (P < 0.01).Compared with HIV group,the level of HIV RNA were 4.8 ± 0.9log/ml and 4.1 ± 1.0log/ml(P < 0.01).Conclution HCV/HIV coinfection can aggravate and accelerate natural course of HCV and HIV disease.High level of HCV RNA of HCV/HIV coinfected patients is a risk factor for worsening the natural course of HCV and HIV diseases.
出处
《医学研究杂志》
2014年第4期91-95,共5页
Journal of Medical Research